Market Overview

UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

Related HCN
Is Ventas's Astounding 320% 10-Year Shareholder Return Plausible Going Forward? Q3 Earnings & Future Focus
Right Time to Build Positions in REIT Stocks? - Zacks Analyst Interviews

JP Morgan reiterated its Overweight rating on Health Care REIT (NYSE: HCN) and increased its price target from $61 to $62.

JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield."

Health Care REIT closed at $60.17 on Thursday.

Latest Ratings for HCN

DateFirmActionFromTo
Nov 2014CitigroupMaintainsNeutral
Nov 2014Evercore ISIDowngradesBuyHold
Oct 2014ISI GroupInitiates Coverage onBuy

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (HCN)

Around the Web, We're Loving...

Get Benzinga's Newsletters